Ankle Implant for Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the Zimmer Trabecular Metal Total Ankle System, a special ankle implant, to evaluate its effectiveness for people with ankle arthritis. The goal is to assess the implant's durability and its impact on pain reduction and daily life improvement. It is open to individuals requiring first-time or replacement ankle surgery due to arthritis, whether from wear and tear, rheumatoid arthritis, or an old injury. As an unphased trial, this study provides a unique opportunity to contribute to advancements in ankle arthritis treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this ankle implant is safe for arthritis patients?
Research has shown that the Zimmer Trabecular Metal Total Ankle System has undergone thorough testing for safety and effectiveness. A study in The Journal of Bone and Joint Surgery highlighted its excellent durability and long-term success for ankle replacement. Another study examined its safety in patients who received this ankle implant and found it was generally well-tolerated, with most patients experiencing good results.
While no treatment is without risk, the Zimmer Total Ankle System has demonstrated a strong safety record in past patients. There have been no major reports of serious unexpected complications linked to the implant, suggesting it is a safe option for those considering ankle replacement surgery.12345Why are researchers excited about this trial?
The Zimmer Trabecular Metal Total Ankle System is unique because it uses a special type of porous metal that resembles bone structure, promoting better integration with the surrounding bone. This is a big leap forward from traditional ankle replacement options, which typically use solid metal components. Researchers are excited about this treatment as it potentially offers improved stability and longevity for patients with arthritis in the ankle, reducing the likelihood of loosening over time. Plus, it can be used for both primary and revision surgeries, making it a versatile option for those needing a replacement or an upgrade from earlier implants.
What evidence suggests that the Zimmer Trabecular Metal Total Ankle System is effective for arthritis?
Research shows that the Zimmer Trabecular Metal Total Ankle System, which participants in this trial will receive, effectively treats severe ankle arthritis. Studies have found that patients experience significantly less pain and improved movement over the long term. The implant is durable, ensuring longevity. Reports also highlight a special surgical method that contributes to the system's success. Overall, the Zimmer system is a dependable option for those needing ankle replacement surgery.12467
Who Is on the Research Team?
Hillary Overholser, MS
Principal Investigator
Zimmer Biomet
Are You a Good Fit for This Trial?
This trial is for adults over 18 with arthritis (degenerative, rheumatoid, or post-traumatic) who need ankle replacement surgery. They must be able to consent and follow the study's procedures. Excluded are prisoners, those mentally unable to participate, non-compliant individuals, pregnant women, patients with infections or poor bone quality, and those with severe limb issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo preoperative clinical evaluations prior to their primary or revision total ankle arthroplasty
Treatment
Participants receive the Zimmer Trabecular Metal Total Ankle System during primary or revision total ankle arthroplasty
Post-operative Evaluation
Post-operative clinical and radiographic evaluations conducted at 6 weeks, 6 months, 1 year, 2, 3, 5, 7, and 10 years
Follow-up Surveys
Follow-up surveys conducted at 4, 6, 8, and 9 years to assess long-term outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Zimmer Trabecular Metal Total Ankle System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business